Presenter's Information
Hyo-Soo Kim, MD
Country | Korea (Republic of) |
Specialty | Interventional Cardiologist |
- Long-Term Antiplatelet Management Beyond 1-Year Post-ACS or Post-PCI
- Aspirin Versus Clopidogrel for Chronic Monotherapy After PCI: HOST-EXAM and HOST-EXAM Extended Study
- Lotus
- Optimal Antithrombotic Treatment and How Long?
- TAVI as an Urgent Salvage Treatment Modality for a Patient with Multi-Organ Failure on Severe AS
- Lotus
- Self-Expanding Evolut R Valve
- Why Stent Platform Matters to Perform a Good PCI
- Issue of Coronary Obstruction in TAVI: Low Height of Coronary Ostium & Countermeasure
- Paravalve Leak: Mechanism and Prevention
- Meta-analysis of Various DES: International and Korean Studies
- How to Avoid Patient-Valve Mismatch and Paravalvular Leak
- Real World Use of BES in Korea : from the Host Biolimus A9¢â Registry
- Endeavor Resolute Stent
- Meta Analysis Results of EES vs SES
- Optimal Regiment or Duration of Anti-platelet Therapy: Dual vs Triple, 6 vs 12 Months
- Strategy to Overcome the Limited Therapeutic Efficacy of the Current Cell Therapy
- Heterogeneity of Endothelial Progenitor Cells and Synergism between? Two Types of EPCs